Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-1 of 1

Sort by

Sort Order Select

Journal Articles

TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms

Roman R. Schimmer, Larisa V. Kovtonyuk, Nancy Klemm, Jonas Fullin, Sebastian M. Stolz, Jan Mueller, Francisco Caiado, Kari J. Kurppa, Benjamin L. Ebert, Markus G. Manz, Steffen Boettcher

Blood Adv (2022) 6 (11): 3201–3206.

https://doi.org/10.1182/bloodadvances.2021005859

Published: 2022

Includes: Supplemental data